Cargando…

Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms

OBJECTIVE: A simple rapid, accurate, precise, and reproducible validated reverse phase high performance liquid chromatography (HPLC) method was developed for the determination of Abacavir (ABAC) and Lamivudine (LAMI) in bulk and tablet dosage forms. METHODS: The quantification was carried out using...

Descripción completa

Detalles Bibliográficos
Autores principales: Raees Ahmad, Sufiyan Ahmad, Patil, Lalit, Mohammed Usman, Mohammed Rageeb, Imran, Mohammad, Akhtar, Rashid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855381/
https://www.ncbi.nlm.nih.gov/pubmed/29568194
http://dx.doi.org/10.4103/pr.pr_96_17
_version_ 1783307090228412416
author Raees Ahmad, Sufiyan Ahmad
Patil, Lalit
Mohammed Usman, Mohammed Rageeb
Imran, Mohammad
Akhtar, Rashid
author_facet Raees Ahmad, Sufiyan Ahmad
Patil, Lalit
Mohammed Usman, Mohammed Rageeb
Imran, Mohammad
Akhtar, Rashid
author_sort Raees Ahmad, Sufiyan Ahmad
collection PubMed
description OBJECTIVE: A simple rapid, accurate, precise, and reproducible validated reverse phase high performance liquid chromatography (HPLC) method was developed for the determination of Abacavir (ABAC) and Lamivudine (LAMI) in bulk and tablet dosage forms. METHODS: The quantification was carried out using Symmetry Premsil C18 (250 mm × 4.6 mm, 5 μm) column run in isocratic way using mobile phase comprising methanol: water (0.05% orthophosphoric acid with pH 3) 83:17 v/v and a detection wavelength of 245 nm and injection volume of 20 μl, with a flow rate of 1 ml/min. RESULTS: In the developed method, the retention times of ABAC and LAMI were found to be 3.5 min and 7.4 min, respectively. The method was validated in terms of linearity, precision, accuracy, limits of detection, limits of quantitation, and robustness in accordance with the International Conference on Harmonization guidelines. CONCLUSION: The assay of the proposed method was found to be 99% – 101%. The recovery studies were also carried out and mean % recovery was found to be 99% – 101%. The % relative standard deviation from reproducibility was found to be <2%. The proposed method was statistically evaluated and can be applied for routine quality control analysis of ABAC and LAMI in bulk and in tablet dosage form. SUMMARY: Attempts were made to develop RP-HPLC method for simultaneous estimation of Abacavir and Lamivudine for the RP-HPLC method. The developed method was validated according to the ICH guidelines. The linearity, precision, range, robustness were within the limits as specified by the ICH guidelines. Hence the method was found to be simple, accurate, precise, economic and reproducible. So the proposed methods can be used for the routine quality control analysis of Abacavir and Lamivudine in bulk drug as well as in formulations. [Image: see text] Abbreviations Used: HPLC: High-performance liquid chromatography, UV: Ultraviolet, ICH: International Conference on Harmonization, ABAC: Abacavir, LAMI: Lamivudine, HIV: Human immunodeficiency virus, AIDS: Acquired immunodeficiency syndrome, NRTI: Nucleoside reverse transcriptase inhibitors, ARV: Antiretroviral, RSD: Relative standard deviation, RT: Retention time, SD: Standard deviation.
format Online
Article
Text
id pubmed-5855381
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58553812018-03-22 Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms Raees Ahmad, Sufiyan Ahmad Patil, Lalit Mohammed Usman, Mohammed Rageeb Imran, Mohammad Akhtar, Rashid Pharmacognosy Res Original Article OBJECTIVE: A simple rapid, accurate, precise, and reproducible validated reverse phase high performance liquid chromatography (HPLC) method was developed for the determination of Abacavir (ABAC) and Lamivudine (LAMI) in bulk and tablet dosage forms. METHODS: The quantification was carried out using Symmetry Premsil C18 (250 mm × 4.6 mm, 5 μm) column run in isocratic way using mobile phase comprising methanol: water (0.05% orthophosphoric acid with pH 3) 83:17 v/v and a detection wavelength of 245 nm and injection volume of 20 μl, with a flow rate of 1 ml/min. RESULTS: In the developed method, the retention times of ABAC and LAMI were found to be 3.5 min and 7.4 min, respectively. The method was validated in terms of linearity, precision, accuracy, limits of detection, limits of quantitation, and robustness in accordance with the International Conference on Harmonization guidelines. CONCLUSION: The assay of the proposed method was found to be 99% – 101%. The recovery studies were also carried out and mean % recovery was found to be 99% – 101%. The % relative standard deviation from reproducibility was found to be <2%. The proposed method was statistically evaluated and can be applied for routine quality control analysis of ABAC and LAMI in bulk and in tablet dosage form. SUMMARY: Attempts were made to develop RP-HPLC method for simultaneous estimation of Abacavir and Lamivudine for the RP-HPLC method. The developed method was validated according to the ICH guidelines. The linearity, precision, range, robustness were within the limits as specified by the ICH guidelines. Hence the method was found to be simple, accurate, precise, economic and reproducible. So the proposed methods can be used for the routine quality control analysis of Abacavir and Lamivudine in bulk drug as well as in formulations. [Image: see text] Abbreviations Used: HPLC: High-performance liquid chromatography, UV: Ultraviolet, ICH: International Conference on Harmonization, ABAC: Abacavir, LAMI: Lamivudine, HIV: Human immunodeficiency virus, AIDS: Acquired immunodeficiency syndrome, NRTI: Nucleoside reverse transcriptase inhibitors, ARV: Antiretroviral, RSD: Relative standard deviation, RT: Retention time, SD: Standard deviation. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5855381/ /pubmed/29568194 http://dx.doi.org/10.4103/pr.pr_96_17 Text en Copyright: © 2018 Pharmacognosy Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Raees Ahmad, Sufiyan Ahmad
Patil, Lalit
Mohammed Usman, Mohammed Rageeb
Imran, Mohammad
Akhtar, Rashid
Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms
title Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms
title_full Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms
title_fullStr Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms
title_full_unstemmed Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms
title_short Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms
title_sort analytical method development and validation for the simultaneous estimation of abacavir and lamivudine by reversed-phase high-performance liquid chromatography in bulk and tablet dosage forms
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855381/
https://www.ncbi.nlm.nih.gov/pubmed/29568194
http://dx.doi.org/10.4103/pr.pr_96_17
work_keys_str_mv AT raeesahmadsufiyanahmad analyticalmethoddevelopmentandvalidationforthesimultaneousestimationofabacavirandlamivudinebyreversedphasehighperformanceliquidchromatographyinbulkandtabletdosageforms
AT patillalit analyticalmethoddevelopmentandvalidationforthesimultaneousestimationofabacavirandlamivudinebyreversedphasehighperformanceliquidchromatographyinbulkandtabletdosageforms
AT mohammedusmanmohammedrageeb analyticalmethoddevelopmentandvalidationforthesimultaneousestimationofabacavirandlamivudinebyreversedphasehighperformanceliquidchromatographyinbulkandtabletdosageforms
AT imranmohammad analyticalmethoddevelopmentandvalidationforthesimultaneousestimationofabacavirandlamivudinebyreversedphasehighperformanceliquidchromatographyinbulkandtabletdosageforms
AT akhtarrashid analyticalmethoddevelopmentandvalidationforthesimultaneousestimationofabacavirandlamivudinebyreversedphasehighperformanceliquidchromatographyinbulkandtabletdosageforms